Pharmaceutical Manufacturing Equipment Market by Equipment Type (Packaging, Mixing & Blending, Filling, Milling, Spray Drying, Inspection, Extrusion, Tablet Compression Presses), End-Product Type (Solid, Liquid) and Region - Global Forecast to 2028
Pharmaceutical Manufacturing Equipment Market by Equipment Type (Packaging, Mixing & Blending, Filling, Milling, Spray Drying, Inspection, Extrusion, Tablet Compression Presses), End-Product Type (Solid, Liquid) and Region - Global Forecast to 2028
Abstract
The pharmaceutical manufacturing equipment market is projected to reach USD 19.7 billion by 2028 from USD 14.5 billion in 2023, at a CAGR of 6.3% from 2023 to 2028. The major factors driving the market growth of the pharmaceutical manufacturing equipment market include increasing number of regulatory frameworks established worldwide to support innovation and safety in drugs, growing demand for generics globally, rising healthcare investment, and growing requirement for flexibility in pharmaceutical manufacturing. Emerging markets for pharmaceutical manufacturing, especially in the Middle East and Africa, is also a key factor driving the demand for technologically advanced pharmaceutical manufacturing equipment.
Packaging machines are expected to register the highest CAGR during the forecast period followed by spray drying equipment
Pharmaceutical packaging machines are critical in the drug manufacturing process as they ensure the quality and safety of medications while meeting regulatory requirements. ackaging machines equipped with serialization capabilities enable unique identification and tracking of individual pharmaceutical products, facilitating supply chain transparency and product authentication, thereby driving their demand.
There is a growing emphasis on sustainable packaging practices in the pharmaceutical industry. Packaging machines that support eco-friendly packaging materials, such as recyclable or biodegradable materials, are in demand. Using pharmaceutical spray drying equipment helps ensure that the active pharmaceutical ingredient (API) is evenly distributed throughout the drug formulation and that the final product meets the required specifications for quality, purity, and potency. The efficient and precise spray drying of drug formulations is essential to produce high-quality drug products that are safe and effective for patient use, thereby driving their demand.
Liquid end-product type is expected to register the highest CAGR during the forecast period followed by solid end-product type
Liquid end-product type covers different types of liquid dosage forms including solutions, syrups, suspensions, and emulsions, among others. There is a growing demand for syrups. They offer accurate dosage of drug in a concentrated sugar solution, thus masking the unpleasant taste and therefore being preferred, especially by the geriatric population and children.
Technological advancements, extensive research and development activities, and innovation in clinical trials have allowed manufacturers to substantially enhance shelf-life of liquid dosage forms, thereby making them a feasible alternative to many solid dosage forms which have less solubility. Liquid medications have higher bioavailability compared to solid dosage forms, meaning that more of the active ingredient is absorbed into the bloodstream. This can lead to a more effective treatment and a reduced risk of side effects, which is another factor driving their demand.
Asia Pacific is expected to register the highest CAGR during forecast period followed by Europe
Industry players in Asia Pacific are working collaboratively with the government to tackle the shortages of drugs. In addition, high-rate of branded drugs and the expiry of key drug patents are also driving the demand for the adoption of generics. The governments and industry players across the region aim to improve pharmaceutical manufacturing facilities by adopting the latest pharmaceutical manufacturing equipment to serve the growing demand for drugs, eliminate drug shortages, and expand production capacities.
India has the highest number of US-FDA-compliant pharma plants outside the US. It is home to over 3,000 pharma companies with a strong network of over 10,500 manufacturing facilities and a highly skilled resource pool. Furthermore, the government of India has implemented schemes, including the Production Linked Incentive (PLI) scheme to boost domestic manufacturing capacity, including high-value products across the global supply chain.
Germany was one of the top importers and exporters of pharmaceutical products in FY 2021. The presence of a favorable policy framework, a well-established healthcare system, increasing pharmaceutical R&D expenditure, and rising demand for branded and generic drugs are the major factors driving the potential of the pharmaceutical market in the country. Germany is home to several major pharmaceutical companies, including Bayer, Merck KGaA, Boehringer Ingelheim, etc.
Several pharmaceutical companies indicate the presence of several major pharmaceutical manufacturing facilities in the country, boosting the adoption of pharmaceutical manufacturing equipment across the country. The French government implemented several measures to streamline the regulatory process and promote research and development. For instance, in 2023, the government will form a new dedicated committee, which will include representatives of the French pharma industry, health professionals, and patients to lay the foundations for a longer-term approach to preventing and managing supply chain issues.
The break-up of profile of primary participants in the pharmaceutical manufacturing equipment market-
•By Company Type: Tier 1 – 40%, Tier 2 – 35%, Tier 3 – 25%
•By Designation Type: C Level – 48%, Director Level – 33% , Others – 19%
•By Region Type: North America – 35%, Europe – 18%, Asia Pacific – 40%, Rest of the World – 7%
The major players of pharmaceutical manufacturing equipment market are GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc.(US) among others.
Research Coverage
The report segments the pharmaceutical manufacturing equipment market and forecasts its size based on equipment type, end-product type, and region. The report also provides a comprehensive review of drivers, restraints, opportunities, and challenges influencing the market growth. The report also covers qualitative aspects in addition to the quantitative aspects of the market.
Reasons to buy the report:
The report will help the market leaders/new entrants in this market with information on the closest approximate revenues for the overall pharmaceutical manufacturing equipment market and related segments. This report will help stakeholders understand the competitive landscape and gain more insights to strengthen their position in the market and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
•Analysis of key drivers (globally increasing demand for generics, rising need for flexible pharmaceutical manufacturing, and growing implementation of regulatory frameworks and guidelines), restraints (increasing global demand for refurbished pharmaceutical manufacturing equipment), opportunities (adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages, emerging markets and increasing focus on sustainability, and integration of artificial intelligence (AI) with inspection equipment to provide better quality assurance), and challenges (rising costs and expenditures related to usage of pharmaceutical manufacturing equipment) influencing the growth of the pharmaceutical manufacturing equipment market
•Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the pharmaceutical manufacturing equipment market
•Market Development: Comprehensive information about lucrative markets – the report analyses the pharmaceutical manufacturing equipment market across varied regions
•Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical manufacturing equipment market
•Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players like GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc.(US).
Content
Table of Contents
1INTRODUCTION31
1.1STUDY OBJECTIVES31
1.2MARKET DEFINITION31
1.3INCLUSIONS AND EXCLUSIONS32
TABLE 1PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: INCLUSIONS AND EXCLUSIONS32
1.4STUDY SCOPE32
1.4.1MARKETS COVERED32
FIGURE 1PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: SEGMENTATION32
1.4.2GEOGRAPHICAL SCOPE33
FIGURE 2PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: GEOGRAPHIC SEGMENTATION33
1.4.3YEARS CONSIDERED33
1.5CURRENCY CONSIDERED34
1.6LIMITATIONS34
1.7STAKEHOLDERS34
1.8RECESSION IMPACT34
2RESEARCH METHODOLOGY35
2.1RESEARCH DATA35
FIGURE 3PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH DESIGN35
2.1.1SECONDARY AND PRIMARY RESEARCH37
2.1.2SECONDARY DATA37
2.1.2.1Major secondary sources38
2.1.2.2Key data from secondary sources38
2.1.3PRIMARY DATA38
2.1.3.1Primary interviews with experts39
2.1.3.2Key data from primary sources39
2.1.3.3Key industry insights40
2.1.3.4Breakdown of primaries40
2.2MARKET SIZE ESTIMATION40
FIGURE 4MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE): REVENUE GENERATED FROM PHARMACEUTICAL PACKAGING MACHINES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET41
2.2.1BOTTOM-UP APPROACH42
2.2.1.1Approach to arrive at market size through bottom-up analysis (demand side)42
FIGURE 5MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH42
2.2.2TOP-DOWN APPROACH43
2.2.2.1Approach to arrive at market size through top-down analysis (supply side)43
FIGURE 6MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH43
2.3MARKET BREAKDOWN AND DATA TRIANGULATION44
FIGURE 7DATA TRIANGULATION44
2.4RESEARCH ASSUMPTIONS45
FIGURE 8ASSUMPTIONS FOR RESEARCH STUDY45
2.5PARAMETERS CONSIDERED TO ANALYZE RECESSION IMPACT46
2.6RESEARCH LIMITATIONS AND RISK ASSESSMENT46
TABLE 2LIMITATIONS AND ASSOCIATED RISKS46
3EXECUTIVE SUMMARY47
FIGURE 9PACKAGING MACHINES TO HOLD DOMINANT SHARE OF MARKET48
FIGURE 10LIQUID END PRODUCT TYPE TO CLAIM LARGEST SHARE IN MARKET48
FIGURE 11ASIA PACIFIC HELD LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN 202249
4PREMIUM INSIGHTS50
4.1ATTRACTIVE GROWTH OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET50
FIGURE 12RISING DEMAND FOR GENERICS AND GROWING NECESSITY FOR FLEXIBLE PHARMACEUTICAL MANUFACTURING TO PROVIDE OPPORTUNITIES FOR PLAYERS IN MARKET50
4.2PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE51
FIGURE 13PACKAGING MACHINES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD51
4.3PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE51
FIGURE 14LIQUID SEGMENT TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD51
4.4PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY52
FIGURE 15US TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD52
5MARKET OVERVIEW53
5.1INTRODUCTION53
5.2MARKET DYNAMICS53
FIGURE 16PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES53
5.2.1DRIVERS54
5.2.1.1Rising demand for generics54
5.2.1.2Need for flexible pharmaceutical manufacturing54
5.2.1.3Growing implementation and adoption of regulatory guidelines54
FIGURE 17PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF DRIVERS55
5.2.2RESTRAINTS56
5.2.2.1Demand for refurbished equipment56
FIGURE 18PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF RESTRAINTS56
5.2.3OPPORTUNITIES57
5.2.3.1Adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages57
5.2.3.2Integration of artificial intelligence with inspection equipment to provide better quality assurance57
5.2.3.3Emerging markets and increased focus on sustainability57
FIGURE 19PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF OPPORTUNITIES58
5.2.4CHALLENGES58
5.2.4.1Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment58
FIGURE 20PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF CHALLENGES59
5.3VALUE CHAIN ANALYSIS59
FIGURE 21PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: VALUE CHAIN ANALYSIS59
5.4ECOSYSTEM MAPPING61
FIGURE 22PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: ECOSYSTEM ANALYSIS61
TABLE 3COMPANIES AND THEIR ROLE IN PHARMACEUTICAL MANUFACTURING EQUIPMENT ECOSYSTEM61
5.5PRICING ANALYSIS62
5.5.1COMPANY-WISE AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT, BY EQUIPMENT TYPE62
TABLE 4AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT, BY EQUIPMENT TYPE62
FIGURE 23AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT BY KEY PLAYERS, BY EQUIPMENT TYPE (USD)63
TABLE 5AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT OFFERED BY THREE GLOBAL PLAYERS, BY EQUIPMENT TYPE63
TABLE 6AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING MACHINE, BY REGION64
FIGURE 24AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING MACHINE, 2019–202864
5.6TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS65
FIGURE 25TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS65
5.7TECHNOLOGY ANALYSIS65
5.7.1INDUSTRY 4.065
5.7.2COMPUTER VISION65
5.7.3RADIO FREQUENCY IDENTIFICATION66
5.8PORTER’S FIVE FORCES ANALYSIS66
FIGURE 26PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS66
5.8.1BARGAINING POWER OF SUPPLIERS67
5.8.2BARGAINING POWER OF BUYERS67
5.8.3THREAT OF NEW ENTRANTS67
5.8.4THREAT OF SUBSTITUTES67
5.8.5INTENSITY OF COMPETITIVE RIVALRY67
5.9KEY STAKEHOLDERS AND BUYING CRITERIA68
5.9.1KEY STAKEHOLDERS IN BUYING PROCESS68
FIGURE 27INFLUENCE OF STAKEHOLDERS IN PHARMACEUTICAL INDUSTRY ON BUYING PROCESS68
TABLE 7INFLUENCE OF STAKEHOLDERS IN TOP THREE END-USER INDUSTRIES ON BUYING PROCESS68
5.9.2BUYING CRITERIA69
FIGURE 28KEY BUYING CRITERIA FOR PHARMACEUTICAL INDUSTRY69
TABLE 8KEY BUYING CRITERIA OF TOP THREE INDUSTRIES69
5.10CASE STUDIES69
TABLE 9ALCAMI CORPORATION CHOOSES SYNTEGON TO INCREASE ITS VIAL FILLING FLEXIBILITY69
TABLE 10LEADING MANUFACTURER OF GENERIC DRUG PRODUCTS IN RUSSIA CHOOSES GEA GROUP TO EXPAND THEIR REACH AND INTEGRATE ADVANCED MANUFACTURING EQUIPMENT70
TABLE 11CDM LAVOISIER ADOPTS SYNTEGON AIM 3000 FOR INSPECTION OF 30 DIFFERENT PRODUCTS ON FOUR PACKAGING FORMATS70
5.11TRADE ANALYSIS71
FIGURE 29IMPORT DATA FOR MACHINERY FOR FILLING, CLOSING, SEALING, OR LABELLING BOTTLES, CANS, BOXES, BAGS, OR OTHER CONTAINERS; MACHINERY FOR CAPSULING BOTTLES, JARS, TUBES, AND SIMILAR CONTAINERS; MACHINERY FOR AERATING BEVERAGES, 2017–2021 (USD MILLION)71
FIGURE 30EXPORT DATA FOR MACHINERY FOR FILLING, CLOSING, SEALING, OR LABELLING BOTTLES, CANS, BOXES, BAGS, OR OTHER CONTAINERS; MACHINERY FOR CAPSULING BOTTLES, JARS, TUBES, AND SIMILAR CONTAINERS; MACHINERY FOR AERATING BEVERAGES, 2017–2021 (USD MILLION)72
5.12PATENT ANALYSIS73
5.12.1LIST OF MAJOR PATENTS74
TABLE 12KEY PATENTS IN AREA OF PHARMACEUTICAL MANUFACTURING EQUIPMENT74
5.13KEY CONFERENCES AND EVENTS, 2022–202375
TABLE 13PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: REGION-WISE CONFERENCES AND EVENTS75
5.14REGULATIONS AND STANDARDS76
5.14.1REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS76
TABLE 14NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS76
TABLE 15EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS77
TABLE 16ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS77
TABLE 17ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS78
5.14.2STANDARDS78
TABLE 18STANDARDS FOLLOWED BY MANUFACTURERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT78
6PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE79
6.1INTRODUCTION80
FIGURE 31PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE80
FIGURE 32PACKAGING MACHINES TO LEAD MARKET THROUGHOUT FORECAST PERIOD81
TABLE 19PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)81
TABLE 20PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)82
6.2PACKAGING MACHINES82
6.2.1RISING NECESSITY FOR ENSURING PROTECTION AGAINST DAMAGE AND CONTAMINATION82
TABLE 21PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)83
TABLE 22PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)83
TABLE 23PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)83
TABLE 24PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)84
TABLE 25PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)84
TABLE 26PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)84
TABLE 27PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)85
TABLE 28PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)85
6.3FILLING MACHINES85
6.3.1GROWING DEMAND FOR ENSURING PRECISION FILLING OF DRUG FORMULATIONS85
TABLE 29FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)86
TABLE 30FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)86
TABLE 31FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)87
TABLE 32FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)87
TABLE 33FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)87
TABLE 34FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)88
TABLE 35FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)88
TABLE 36FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)88
6.4SPRAY DRYING EQUIPMENT89
6.4.1GROWING NECESSITY FOR HIGH-QUALITY DRUGS89
TABLE 37SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)89
TABLE 38SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)90
TABLE 39SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)90
TABLE 40SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)90
TABLE 41SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)91
TABLE 42SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)91
TABLE 43SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)91
TABLE 44SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)92
6.5MIXING AND BLENDING MACHINES92
6.5.1DEMAND TO MAINTAIN UNIFORMITY OF DRUG FORMULATIONS FOR HOMOGENEITY TO DRIVE MARKET92
TABLE 45MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)93
TABLE 46MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)93
TABLE 47MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)93
TABLE 48MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)94
TABLE 49MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)94
TABLE 50MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)94
TABLE 51MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)95
TABLE 52MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)95
6.6MILLING EQUIPMENT95
6.6.1RISING NECESSITY TO IMPROVE SOLUBILITY OF DRUGS95
TABLE 53MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)96
TABLE 54MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)96
TABLE 55MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)96
TABLE 56MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)97
TABLE 57MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)97
TABLE 58MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)97
TABLE 59MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)98
TABLE 60MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)98
6.7EXTRUSION EQUIPMENT98
6.7.1NECESSITY FOR DEVELOPING DRUGS IN EFFECTIVE SHAPES AND MAINTAINING PROPER DRUG FORMULATION98
TABLE 61EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)99
TABLE 62EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)99
TABLE 63EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)100
TABLE 64EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)100
TABLE 65EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)100
TABLE 66EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)101
TABLE 67EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)101
TABLE 68EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)101
6.8TABLET COMPRESSION PRESSES102
6.8.1RISING DEMAND TO PRODUCE LARGE BATCHES OF TABLETS QUICKLY102
TABLE 69TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)102
TABLE 70TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)103
TABLE 71TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)103
TABLE 72TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)103
TABLE 73TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)104
TABLE 74TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)104
TABLE 75TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)104
TABLE 76TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)105
6.9INSPECTION EQUIPMENT105
6.9.1RISING DEMAND TO ADHERE TO QUALITY STANDARDS105
TABLE 77INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)106
TABLE 78INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)106
TABLE 79INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)106
TABLE 80INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)107
TABLE 81INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)107
TABLE 82INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)107
TABLE 83INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)108
TABLE 84INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)108
7PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE109
7.1INTRODUCTION110
FIGURE 33LIQUID END-PRODUCT TYPE TO HOLD LARGER MARKET SHARE THROUGHOUT FORECAST PERIOD110
TABLE 85PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2019–2022 (USD MILLION)110
TABLE 86PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2023–2028 (USD MILLION)111
7.2SOLID111
7.2.1RISING DEMAND FOR TABLETS111
7.3LIQUID112
7.3.1EASE OF ADMINISTRATION AND HIGH SOLUBILITY112
8PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION113
8.1INTRODUCTION114
FIGURE 34INDIA TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD114
FIGURE 35ASIA PACIFIC TO ACCOUNT FOR LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD115
TABLE 87PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)115
TABLE 88PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)115
8.2NORTH AMERICA116
FIGURE 36NORTH AMERICA: SNAPSHOT OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET117
FIGURE 37US TO REGISTER HIGHEST CAGR IN NORTH AMERICAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD118
TABLE 89NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019–2022 (USD MILLION)118
TABLE 90NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023–2028 (USD MILLION)118
TABLE 91US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)119
TABLE 92US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)119
TABLE 93CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)120
TABLE 94CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)120
TABLE 95MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)121
TABLE 96MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)121
TABLE 97NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)122
TABLE 98NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)122
8.2.1US123
8.2.1.1Stringent regulatory framework and growing demand for innovative drugs123
8.2.2CANADA123
8.2.2.1Establishment of new drug development facilities and government measures123
8.2.3MEXICO124
8.2.3.1Development of pharmaceutical manufacturing units by global players124
8.3EUROPE124
FIGURE 38EUROPE: SNAPSHOT OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET125
FIGURE 39GERMANY TO REGISTER HIGHEST CAGR IN EUROPEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD126
TABLE 99EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019–2022 (USD MILLION)126
TABLE 100EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023–2028 (USD MILLION)126
TABLE 101UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)127
TABLE 102UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)127
TABLE 103GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)128
TABLE 104GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)128
TABLE 105FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)129
TABLE 106FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)129
TABLE 107ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)130
TABLE 108ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)130
TABLE 109EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)131
TABLE 110EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)131
8.3.1UK132
8.3.1.1Strong pharmaceutical manufacturing sector132
8.3.2GERMANY132
8.3.2.1Presence of major pharmaceutical players132
8.3.3FRANCE132
8.3.3.1Growing demand for generics132
8.3.4ITALY133
8.3.4.1Growing government support133
8.3.5REST OF EUROPE133
8.4ASIA PACIFIC134
FIGURE 40ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT135
FIGURE 41INDIA TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD136
TABLE 111ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019–2022 (USD MILLION)136
TABLE 112ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023–2028 (USD MILLION)136
TABLE 113CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)137
TABLE 114CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)137
TABLE 115JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)138
TABLE 116JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)138
TABLE 117INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)139
TABLE 118INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)139
TABLE 119SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)140
TABLE 120SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)140
TABLE 121ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)141
TABLE 122ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)141
8.4.1CHINA142
8.4.1.1Growing contract pharmaceutical manufacturing142
8.4.2JAPAN142
8.4.2.1Collaboration of associations and industry players to eliminate drug shortages142
8.4.3INDIA143
8.4.3.1Establishment of new pharmaceutical manufacturing units143
8.4.4SOUTH KOREA143
8.4.4.1Increasing government initiatives to support market growth143
8.4.5REST OF ASIA PACIFIC143
8.5REST OF THE WORLD144
FIGURE 42SOUTH AMERICA TO DOMINATE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW DURING FORECAST PERIOD144
TABLE 123ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)144
TABLE 124ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2023–2028 (USD MILLION)145
TABLE 125ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)145
TABLE 126ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)145
8.5.1MIDDLE EAST & AFRICA146
8.5.1.1Growing regulatory environment146
8.5.2SOUTH AMERICA146
8.5.2.1Growing pharmaceutical manufacturing infrastructure146
9COMPETITIVE LANDSCAPE147
9.1OVERVIEW147
TABLE 127OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET147
9.2REVENUE ANALYSIS OF TOP FIVE PLAYERS149
FIGURE 43PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE ANALYSIS (2022)149
9.3MARKET SHARE ANALYSIS, 2022149
TABLE 128PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE OF KEY COMPANIES150
FIGURE 44PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE ANALYSIS150
9.4COMPANY EVALUATION QUADRANT152
9.4.1STARS152
9.4.2EMERGING LEADERS152
9.4.3PERVASIVE PLAYERS152
9.4.4PARTICIPANTS152
FIGURE 45PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: COMPANY EVALUATION QUADRANT, 2022153
9.5SMALL- AND MEDIUM-SIZED ENTERPRISES EVALUATION QUADRANT, 2022154
9.5.1PROGRESSIVE COMPANIES154
9.5.2RESPONSIVE COMPANIES154
9.5.3DYNAMIC COMPANIES154
9.5.4STARTING BLOCKS154
FIGURE 46PHARMACEUTICAL PACKAGING EQUIPMENT MARKET (GLOBAL): SME EVALUATION QUADRANT, 2022155
9.6PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: COMPANY FOOTPRINT156
TABLE 129COMPANY FOOTPRINT156
TABLE 130PRIMARY PACKAGING EQUIPMENT: COMPANY FOOTPRINT157
TABLE 131SECONDARY PACKAGING EQUIPMENT: COMPANY FOOTPRINT158
TABLE 132TYPE: COMPANY FOOTPRINT159
TABLE 133REGION: COMPANY FOOTPRINT161
9.7COMPETITIVE BENCHMARKING162
TABLE 134PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES162
TABLE 135PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES163
9.8COMPETITIVE SITUATIONS AND TRENDS165
9.8.1PRODUCT LAUNCHES165
TABLE 136PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PRODUCT LAUNCHES, APRIL 2020–JANUARY 2023165
9.8.2DEALS166
TABLE 137PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DEALS, JANUARY 2021–MARCH 2023166
10COMPANY PROFILES169
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
10.1KEY PLAYERS169
10.1.1GEA GROUP AKTIENGESELLSCHAFT169
TABLE 138GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW169
FIGURE 47GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT170
TABLE 139GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED170
TABLE 140GEA GROUP AKTIENGESELLSCHAFT: PRODUCT LAUNCHES & DEVELOPMENTS171
TABLE 141GEA GROUP AKTIENGESELLSCHAFT: DEALS172
10.1.2I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A173
TABLE 142I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A : COMPANY OVERVIEW173
TABLE 143I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A: PRODUCT/SOLUTIONS/SERVICES OFFERED173
10.1.3SYNTEGON TECHNOLOGY GMBH176
TABLE 144SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW176
TABLE 145SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED177
TABLE 146SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES178
TABLE 147SYNTEGON TECHNOLOGY GMBH: DEALS178
10.1.4ACG180
TABLE 148ACG: COMPANY OVERVIEW180
TABLE 149ACG: PRODUCTS/SOLUTIONS/SERVICES OFFERED180
10.1.5THERMO FISHER SCIENTIFIC INC.183
TABLE 150THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW183
FIGURE 48THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT184
TABLE 151THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED184
TABLE 152THERMO FISHER SCIENTIFIC INC.: DEALS185
10.1.6ROMACO GROUP187
TABLE 153ROMACO GROUP: COMPANY OVERVIEW187
TABLE 154ROMACO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED187
TABLE 155ROMACO GROUP: PRODUCT LAUNCHES188
TABLE 156ROMACO GROUP: DEALS189
10.1.7KÖRBER AG190
TABLE 157KÖRBER AG: COMPANY OVERVIEW190
FIGURE 49KÖRBER AG: COMPANY SNAPSHOT191
TABLE 158KÖRBER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED191
TABLE 159KÖRBER AG: DEALS192
10.1.8MARCHESINI GROUP193
TABLE 160MARCHESINI GROUP: COMPANY OVERVIEW193
TABLE 161MARCHESINI GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED193
TABLE 162MARCHESINI GROUP: PRODUCT LAUNCHES194
TABLE 163MARCHESINI GROUP: DEALS195
10.1.9MG2 S.R.L196
TABLE 164MG2 S.R.L.: COMPANY OVERVIEW196
TABLE 165MG2 S.R.L.: PRODUCTS/SOLUTIONS/SERVICES OFFERED196
TABLE 166MG2 S.R.L.: PRODUCT LAUNCHES197
10.1.10GLATT GMBH198
TABLE 167GLATT GMBH: COMPANY OVERVIEW198
TABLE 168GLATT GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED199
10.2OTHER PLAYERS200
10.2.1BAKER PERKINS200
TABLE 169BAKER PERKINS: COMPANY OVERVIEW200
10.2.2BAUSCH+STRÖBEL201
TABLE 170BAUSCH+ STRÖBEL: COMPANY OVERVIEW201
10.2.3COPERION202
TABLE 171COPERION: COMPANY OVERVIEW202
10.2.4ELIZABETH COMPANIES203
TABLE 172ELIZABETH COMPANIES: COMPANY OVERVIEW203
10.2.5FETTE COMPACTING203
TABLE 173FETTE COMPACTING: COMPANY OVERVIEW203
10.2.6FREUND-VECTOR204
TABLE 174FREUND-VECTOR: COMPANY OVERVIEW204
10.2.7KORSCH205
TABLE 175KORSCH: COMPANY OVERVIEW205
10.2.8L.B. BOHLE206
TABLE 176L.B. BOHLE: COMPANY OVERVIEW206
10.2.9LFA MACHINES206
TABLE 177LFA MACHINES: COMPANY OVERVIEW206
10.2.10CVC TECHNOLOGIES, INC.207
TABLE 178CVC TECHNOLOGIES, INC.: COMPANY OVERVIEW207
10.2.11OHARA TECHNOLOGIES207
TABLE 179OHARA TECHNOLOGIES: COMPANY OVERVIEW207
10.2.12PRISM PHARMA MACHINERY208
TABLE 180PRISM PHARMA MACHINERY: COMPANY OVERVIEW208
10.2.13SAINTYCO209
TABLE 181SAINTYCO: COMPANY OVERVIEW209
10.2.14SILVERSON209
TABLE 182SILVERSON: COMPANY OVERVIEW209
10.2.15YENCHEN MACHINERY210
TABLE 183YENCHEN MACHINERY: COMPANY OVERVIEW210
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
11ADJACENT AND RELATED MARKETS211
11.1INTRODUCTION211
11.2LIMITATIONS211
11.3SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT212
11.3.1INTRODUCTION212
TABLE 184SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT, 2019–2022 (USD MILLION)212
TABLE 185SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT, 2023–2028 (USD MILLION)212
11.4IDM FIRMS213
11.4.1FOCUS ON SEMICONDUCTOR DESIGN AND PRODUCTION AND HAVE INTERNAL CAPABILITY TO PERFORM BOTH213
TABLE 186IDM FIRMS: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)213
TABLE 187IDM FIRMS: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)214
11.5OSAT COMPANIES214
11.5.1LESS INVESTMENTS AND ATTRACTIVE REVENUE FOSTER GROWTH OF OSAT COMPANIES214
TABLE 188OSAT COMPANIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)215
TABLE 189OSAT COMPANIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)215
11.6FOUNDRIES215
11.6.1INCREASED SEMICONDUCTOR OUTSOURCING BY FABLESS COMPANIES215
TABLE 190FOUNDRIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)216
TABLE 191FOUNDRIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)216
12APPENDIX217
12.1INSIGHTS FROM INDUSTRY EXPERTS217
12.2DISCUSSION GUIDE218
12.3KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRI
Packaging machines are expected to register the highest CAGR during the forecast period followed by spray drying equipment
Pharmaceutical packaging machines are critical in the drug manufacturing process as they ensure the quality and safety of medications while meeting regulatory requirements. ackaging machines equipped with serialization capabilities enable unique identification and tracking of individual pharmaceutical products, facilitating supply chain transparency and product authentication, thereby driving their demand.
There is a growing emphasis on sustainable packaging practices in the pharmaceutical industry. Packaging machines that support eco-friendly packaging materials, such as recyclable or biodegradable materials, are in demand. Using pharmaceutical spray drying equipment helps ensure that the active pharmaceutical ingredient (API) is evenly distributed throughout the drug formulation and that the final product meets the required specifications for quality, purity, and potency. The efficient and precise spray drying of drug formulations is essential to produce high-quality drug products that are safe and effective for patient use, thereby driving their demand.
Liquid end-product type is expected to register the highest CAGR during the forecast period followed by solid end-product type
Liquid end-product type covers different types of liquid dosage forms including solutions, syrups, suspensions, and emulsions, among others. There is a growing demand for syrups. They offer accurate dosage of drug in a concentrated sugar solution, thus masking the unpleasant taste and therefore being preferred, especially by the geriatric population and children.
Technological advancements, extensive research and development activities, and innovation in clinical trials have allowed manufacturers to substantially enhance shelf-life of liquid dosage forms, thereby making them a feasible alternative to many solid dosage forms which have less solubility. Liquid medications have higher bioavailability compared to solid dosage forms, meaning that more of the active ingredient is absorbed into the bloodstream. This can lead to a more effective treatment and a reduced risk of side effects, which is another factor driving their demand.
Asia Pacific is expected to register the highest CAGR during forecast period followed by Europe
Industry players in Asia Pacific are working collaboratively with the government to tackle the shortages of drugs. In addition, high-rate of branded drugs and the expiry of key drug patents are also driving the demand for the adoption of generics. The governments and industry players across the region aim to improve pharmaceutical manufacturing facilities by adopting the latest pharmaceutical manufacturing equipment to serve the growing demand for drugs, eliminate drug shortages, and expand production capacities.
India has the highest number of US-FDA-compliant pharma plants outside the US. It is home to over 3,000 pharma companies with a strong network of over 10,500 manufacturing facilities and a highly skilled resource pool. Furthermore, the government of India has implemented schemes, including the Production Linked Incentive (PLI) scheme to boost domestic manufacturing capacity, including high-value products across the global supply chain.
Germany was one of the top importers and exporters of pharmaceutical products in FY 2021. The presence of a favorable policy framework, a well-established healthcare system, increasing pharmaceutical R&D expenditure, and rising demand for branded and generic drugs are the major factors driving the potential of the pharmaceutical market in the country. Germany is home to several major pharmaceutical companies, including Bayer, Merck KGaA, Boehringer Ingelheim, etc.
Several pharmaceutical companies indicate the presence of several major pharmaceutical manufacturing facilities in the country, boosting the adoption of pharmaceutical manufacturing equipment across the country. The French government implemented several measures to streamline the regulatory process and promote research and development. For instance, in 2023, the government will form a new dedicated committee, which will include representatives of the French pharma industry, health professionals, and patients to lay the foundations for a longer-term approach to preventing and managing supply chain issues.
The break-up of profile of primary participants in the pharmaceutical manufacturing equipment market-
•By Company Type: Tier 1 – 40%, Tier 2 – 35%, Tier 3 – 25%
•By Designation Type: C Level – 48%, Director Level – 33% , Others – 19%
•By Region Type: North America – 35%, Europe – 18%, Asia Pacific – 40%, Rest of the World – 7%
The major players of pharmaceutical manufacturing equipment market are GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc.(US) among others.
Research Coverage
The report segments the pharmaceutical manufacturing equipment market and forecasts its size based on equipment type, end-product type, and region. The report also provides a comprehensive review of drivers, restraints, opportunities, and challenges influencing the market growth. The report also covers qualitative aspects in addition to the quantitative aspects of the market.
Reasons to buy the report:
The report will help the market leaders/new entrants in this market with information on the closest approximate revenues for the overall pharmaceutical manufacturing equipment market and related segments. This report will help stakeholders understand the competitive landscape and gain more insights to strengthen their position in the market and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
•Analysis of key drivers (globally increasing demand for generics, rising need for flexible pharmaceutical manufacturing, and growing implementation of regulatory frameworks and guidelines), restraints (increasing global demand for refurbished pharmaceutical manufacturing equipment), opportunities (adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages, emerging markets and increasing focus on sustainability, and integration of artificial intelligence (AI) with inspection equipment to provide better quality assurance), and challenges (rising costs and expenditures related to usage of pharmaceutical manufacturing equipment) influencing the growth of the pharmaceutical manufacturing equipment market
•Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the pharmaceutical manufacturing equipment market
•Market Development: Comprehensive information about lucrative markets – the report analyses the pharmaceutical manufacturing equipment market across varied regions
•Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical manufacturing equipment market
•Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players like GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc.(US).
1INTRODUCTION31
1.1STUDY OBJECTIVES31
1.2MARKET DEFINITION31
1.3INCLUSIONS AND EXCLUSIONS32
TABLE 1PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: INCLUSIONS AND EXCLUSIONS32
1.4STUDY SCOPE32
1.4.1MARKETS COVERED32
FIGURE 1PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: SEGMENTATION32
1.4.2GEOGRAPHICAL SCOPE33
FIGURE 2PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: GEOGRAPHIC SEGMENTATION33
1.4.3YEARS CONSIDERED33
1.5CURRENCY CONSIDERED34
1.6LIMITATIONS34
1.7STAKEHOLDERS34
1.8RECESSION IMPACT34
2RESEARCH METHODOLOGY35
2.1RESEARCH DATA35
FIGURE 3PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH DESIGN35
2.1.1SECONDARY AND PRIMARY RESEARCH37
2.1.2SECONDARY DATA37
2.1.2.1Major secondary sources38
2.1.2.2Key data from secondary sources38
2.1.3PRIMARY DATA38
2.1.3.1Primary interviews with experts39
2.1.3.2Key data from primary sources39
2.1.3.3Key industry insights40
2.1.3.4Breakdown of primaries40
2.2MARKET SIZE ESTIMATION40
FIGURE 4MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE): REVENUE GENERATED FROM PHARMACEUTICAL PACKAGING MACHINES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET41
2.2.1BOTTOM-UP APPROACH42
2.2.1.1Approach to arrive at market size through bottom-up analysis (demand side)42
FIGURE 5MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH42
2.2.2TOP-DOWN APPROACH43
2.2.2.1Approach to arrive at market size through top-down analysis (supply side)43
FIGURE 6MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH43
2.3MARKET BREAKDOWN AND DATA TRIANGULATION44
FIGURE 7DATA TRIANGULATION44
2.4RESEARCH ASSUMPTIONS45
FIGURE 8ASSUMPTIONS FOR RESEARCH STUDY45
2.5PARAMETERS CONSIDERED TO ANALYZE RECESSION IMPACT46
2.6RESEARCH LIMITATIONS AND RISK ASSESSMENT46
TABLE 2LIMITATIONS AND ASSOCIATED RISKS46
3EXECUTIVE SUMMARY47
FIGURE 9PACKAGING MACHINES TO HOLD DOMINANT SHARE OF MARKET48
FIGURE 10LIQUID END PRODUCT TYPE TO CLAIM LARGEST SHARE IN MARKET48
FIGURE 11ASIA PACIFIC HELD LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN 202249
4PREMIUM INSIGHTS50
4.1ATTRACTIVE GROWTH OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET50
FIGURE 12RISING DEMAND FOR GENERICS AND GROWING NECESSITY FOR FLEXIBLE PHARMACEUTICAL MANUFACTURING TO PROVIDE OPPORTUNITIES FOR PLAYERS IN MARKET50
4.2PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE51
FIGURE 13PACKAGING MACHINES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD51
4.3PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE51
FIGURE 14LIQUID SEGMENT TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD51
4.4PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY52
FIGURE 15US TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD52
5MARKET OVERVIEW53
5.1INTRODUCTION53
5.2MARKET DYNAMICS53
FIGURE 16PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES53
5.2.1DRIVERS54
5.2.1.1Rising demand for generics54
5.2.1.2Need for flexible pharmaceutical manufacturing54
5.2.1.3Growing implementation and adoption of regulatory guidelines54
FIGURE 17PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF DRIVERS55
5.2.2RESTRAINTS56
5.2.2.1Demand for refurbished equipment56
FIGURE 18PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF RESTRAINTS56
5.2.3OPPORTUNITIES57
5.2.3.1Adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages57
5.2.3.2Integration of artificial intelligence with inspection equipment to provide better quality assurance57
5.2.3.3Emerging markets and increased focus on sustainability57
FIGURE 19PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF OPPORTUNITIES58
5.2.4CHALLENGES58
5.2.4.1Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment58
FIGURE 20PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF CHALLENGES59
5.3VALUE CHAIN ANALYSIS59
FIGURE 21PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: VALUE CHAIN ANALYSIS59
5.4ECOSYSTEM MAPPING61
FIGURE 22PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: ECOSYSTEM ANALYSIS61
TABLE 3COMPANIES AND THEIR ROLE IN PHARMACEUTICAL MANUFACTURING EQUIPMENT ECOSYSTEM61
5.5PRICING ANALYSIS62
5.5.1COMPANY-WISE AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT, BY EQUIPMENT TYPE62
TABLE 4AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT, BY EQUIPMENT TYPE62
FIGURE 23AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT BY KEY PLAYERS, BY EQUIPMENT TYPE (USD)63
TABLE 5AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT OFFERED BY THREE GLOBAL PLAYERS, BY EQUIPMENT TYPE63
TABLE 6AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING MACHINE, BY REGION64
FIGURE 24AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING MACHINE, 2019–202864
5.6TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS65
FIGURE 25TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS65
5.7TECHNOLOGY ANALYSIS65
5.7.1INDUSTRY 4.065
5.7.2COMPUTER VISION65
5.7.3RADIO FREQUENCY IDENTIFICATION66
5.8PORTER’S FIVE FORCES ANALYSIS66
FIGURE 26PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS66
5.8.1BARGAINING POWER OF SUPPLIERS67
5.8.2BARGAINING POWER OF BUYERS67
5.8.3THREAT OF NEW ENTRANTS67
5.8.4THREAT OF SUBSTITUTES67
5.8.5INTENSITY OF COMPETITIVE RIVALRY67
5.9KEY STAKEHOLDERS AND BUYING CRITERIA68
5.9.1KEY STAKEHOLDERS IN BUYING PROCESS68
FIGURE 27INFLUENCE OF STAKEHOLDERS IN PHARMACEUTICAL INDUSTRY ON BUYING PROCESS68
TABLE 7INFLUENCE OF STAKEHOLDERS IN TOP THREE END-USER INDUSTRIES ON BUYING PROCESS68
5.9.2BUYING CRITERIA69
FIGURE 28KEY BUYING CRITERIA FOR PHARMACEUTICAL INDUSTRY69
TABLE 8KEY BUYING CRITERIA OF TOP THREE INDUSTRIES69
5.10CASE STUDIES69
TABLE 9ALCAMI CORPORATION CHOOSES SYNTEGON TO INCREASE ITS VIAL FILLING FLEXIBILITY69
TABLE 10LEADING MANUFACTURER OF GENERIC DRUG PRODUCTS IN RUSSIA CHOOSES GEA GROUP TO EXPAND THEIR REACH AND INTEGRATE ADVANCED MANUFACTURING EQUIPMENT70
TABLE 11CDM LAVOISIER ADOPTS SYNTEGON AIM 3000 FOR INSPECTION OF 30 DIFFERENT PRODUCTS ON FOUR PACKAGING FORMATS70
5.11TRADE ANALYSIS71
FIGURE 29IMPORT DATA FOR MACHINERY FOR FILLING, CLOSING, SEALING, OR LABELLING BOTTLES, CANS, BOXES, BAGS, OR OTHER CONTAINERS; MACHINERY FOR CAPSULING BOTTLES, JARS, TUBES, AND SIMILAR CONTAINERS; MACHINERY FOR AERATING BEVERAGES, 2017–2021 (USD MILLION)71
FIGURE 30EXPORT DATA FOR MACHINERY FOR FILLING, CLOSING, SEALING, OR LABELLING BOTTLES, CANS, BOXES, BAGS, OR OTHER CONTAINERS; MACHINERY FOR CAPSULING BOTTLES, JARS, TUBES, AND SIMILAR CONTAINERS; MACHINERY FOR AERATING BEVERAGES, 2017–2021 (USD MILLION)72
5.12PATENT ANALYSIS73
5.12.1LIST OF MAJOR PATENTS74
TABLE 12KEY PATENTS IN AREA OF PHARMACEUTICAL MANUFACTURING EQUIPMENT74
5.13KEY CONFERENCES AND EVENTS, 2022–202375
TABLE 13PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: REGION-WISE CONFERENCES AND EVENTS75
5.14REGULATIONS AND STANDARDS76
5.14.1REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS76
TABLE 14NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS76
TABLE 15EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS77
TABLE 16ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS77
TABLE 17ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS78
5.14.2STANDARDS78
TABLE 18STANDARDS FOLLOWED BY MANUFACTURERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT78
6PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE79
6.1INTRODUCTION80
FIGURE 31PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE80
FIGURE 32PACKAGING MACHINES TO LEAD MARKET THROUGHOUT FORECAST PERIOD81
TABLE 19PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)81
TABLE 20PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)82
6.2PACKAGING MACHINES82
6.2.1RISING NECESSITY FOR ENSURING PROTECTION AGAINST DAMAGE AND CONTAMINATION82
TABLE 21PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)83
TABLE 22PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)83
TABLE 23PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)83
TABLE 24PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)84
TABLE 25PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)84
TABLE 26PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)84
TABLE 27PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)85
TABLE 28PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)85
6.3FILLING MACHINES85
6.3.1GROWING DEMAND FOR ENSURING PRECISION FILLING OF DRUG FORMULATIONS85
TABLE 29FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)86
TABLE 30FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)86
TABLE 31FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)87
TABLE 32FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)87
TABLE 33FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)87
TABLE 34FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)88
TABLE 35FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)88
TABLE 36FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)88
6.4SPRAY DRYING EQUIPMENT89
6.4.1GROWING NECESSITY FOR HIGH-QUALITY DRUGS89
TABLE 37SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)89
TABLE 38SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)90
TABLE 39SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)90
TABLE 40SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)90
TABLE 41SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)91
TABLE 42SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)91
TABLE 43SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)91
TABLE 44SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)92
6.5MIXING AND BLENDING MACHINES92
6.5.1DEMAND TO MAINTAIN UNIFORMITY OF DRUG FORMULATIONS FOR HOMOGENEITY TO DRIVE MARKET92
TABLE 45MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)93
TABLE 46MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)93
TABLE 47MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)93
TABLE 48MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)94
TABLE 49MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)94
TABLE 50MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)94
TABLE 51MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)95
TABLE 52MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)95
6.6MILLING EQUIPMENT95
6.6.1RISING NECESSITY TO IMPROVE SOLUBILITY OF DRUGS95
TABLE 53MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)96
TABLE 54MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)96
TABLE 55MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)96
TABLE 56MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)97
TABLE 57MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)97
TABLE 58MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)97
TABLE 59MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)98
TABLE 60MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)98
6.7EXTRUSION EQUIPMENT98
6.7.1NECESSITY FOR DEVELOPING DRUGS IN EFFECTIVE SHAPES AND MAINTAINING PROPER DRUG FORMULATION98
TABLE 61EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)99
TABLE 62EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)99
TABLE 63EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)100
TABLE 64EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)100
TABLE 65EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)100
TABLE 66EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)101
TABLE 67EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)101
TABLE 68EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)101
6.8TABLET COMPRESSION PRESSES102
6.8.1RISING DEMAND TO PRODUCE LARGE BATCHES OF TABLETS QUICKLY102
TABLE 69TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)102
TABLE 70TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)103
TABLE 71TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)103
TABLE 72TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)103
TABLE 73TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)104
TABLE 74TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)104
TABLE 75TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)104
TABLE 76TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)105
6.9INSPECTION EQUIPMENT105
6.9.1RISING DEMAND TO ADHERE TO QUALITY STANDARDS105
TABLE 77INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)106
TABLE 78INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)106
TABLE 79INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION)106
TABLE 80INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION)107
TABLE 81INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION)107
TABLE 82INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION)107
TABLE 83INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION)108
TABLE 84INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION)108
7PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE109
7.1INTRODUCTION110
FIGURE 33LIQUID END-PRODUCT TYPE TO HOLD LARGER MARKET SHARE THROUGHOUT FORECAST PERIOD110
TABLE 85PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2019–2022 (USD MILLION)110
TABLE 86PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2023–2028 (USD MILLION)111
7.2SOLID111
7.2.1RISING DEMAND FOR TABLETS111
7.3LIQUID112
7.3.1EASE OF ADMINISTRATION AND HIGH SOLUBILITY112
8PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION113
8.1INTRODUCTION114
FIGURE 34INDIA TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD114
FIGURE 35ASIA PACIFIC TO ACCOUNT FOR LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD115
TABLE 87PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)115
TABLE 88PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)115
8.2NORTH AMERICA116
FIGURE 36NORTH AMERICA: SNAPSHOT OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET117
FIGURE 37US TO REGISTER HIGHEST CAGR IN NORTH AMERICAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD118
TABLE 89NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019–2022 (USD MILLION)118
TABLE 90NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023–2028 (USD MILLION)118
TABLE 91US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)119
TABLE 92US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)119
TABLE 93CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)120
TABLE 94CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)120
TABLE 95MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)121
TABLE 96MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)121
TABLE 97NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)122
TABLE 98NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)122
8.2.1US123
8.2.1.1Stringent regulatory framework and growing demand for innovative drugs123
8.2.2CANADA123
8.2.2.1Establishment of new drug development facilities and government measures123
8.2.3MEXICO124
8.2.3.1Development of pharmaceutical manufacturing units by global players124
8.3EUROPE124
FIGURE 38EUROPE: SNAPSHOT OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET125
FIGURE 39GERMANY TO REGISTER HIGHEST CAGR IN EUROPEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD126
TABLE 99EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019–2022 (USD MILLION)126
TABLE 100EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023–2028 (USD MILLION)126
TABLE 101UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)127
TABLE 102UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)127
TABLE 103GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)128
TABLE 104GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)128
TABLE 105FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)129
TABLE 106FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)129
TABLE 107ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)130
TABLE 108ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)130
TABLE 109EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)131
TABLE 110EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)131
8.3.1UK132
8.3.1.1Strong pharmaceutical manufacturing sector132
8.3.2GERMANY132
8.3.2.1Presence of major pharmaceutical players132
8.3.3FRANCE132
8.3.3.1Growing demand for generics132
8.3.4ITALY133
8.3.4.1Growing government support133
8.3.5REST OF EUROPE133
8.4ASIA PACIFIC134
FIGURE 40ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT135
FIGURE 41INDIA TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD136
TABLE 111ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019–2022 (USD MILLION)136
TABLE 112ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023–2028 (USD MILLION)136
TABLE 113CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)137
TABLE 114CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)137
TABLE 115JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)138
TABLE 116JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)138
TABLE 117INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)139
TABLE 118INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)139
TABLE 119SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)140
TABLE 120SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)140
TABLE 121ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)141
TABLE 122ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)141
8.4.1CHINA142
8.4.1.1Growing contract pharmaceutical manufacturing142
8.4.2JAPAN142
8.4.2.1Collaboration of associations and industry players to eliminate drug shortages142
8.4.3INDIA143
8.4.3.1Establishment of new pharmaceutical manufacturing units143
8.4.4SOUTH KOREA143
8.4.4.1Increasing government initiatives to support market growth143
8.4.5REST OF ASIA PACIFIC143
8.5REST OF THE WORLD144
FIGURE 42SOUTH AMERICA TO DOMINATE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW DURING FORECAST PERIOD144
TABLE 123ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)144
TABLE 124ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2023–2028 (USD MILLION)145
TABLE 125ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION)145
TABLE 126ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION)145
8.5.1MIDDLE EAST & AFRICA146
8.5.1.1Growing regulatory environment146
8.5.2SOUTH AMERICA146
8.5.2.1Growing pharmaceutical manufacturing infrastructure146
9COMPETITIVE LANDSCAPE147
9.1OVERVIEW147
TABLE 127OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET147
9.2REVENUE ANALYSIS OF TOP FIVE PLAYERS149
FIGURE 43PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE ANALYSIS (2022)149
9.3MARKET SHARE ANALYSIS, 2022149
TABLE 128PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE OF KEY COMPANIES150
FIGURE 44PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE ANALYSIS150
9.4COMPANY EVALUATION QUADRANT152
9.4.1STARS152
9.4.2EMERGING LEADERS152
9.4.3PERVASIVE PLAYERS152
9.4.4PARTICIPANTS152
FIGURE 45PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: COMPANY EVALUATION QUADRANT, 2022153
9.5SMALL- AND MEDIUM-SIZED ENTERPRISES EVALUATION QUADRANT, 2022154
9.5.1PROGRESSIVE COMPANIES154
9.5.2RESPONSIVE COMPANIES154
9.5.3DYNAMIC COMPANIES154
9.5.4STARTING BLOCKS154
FIGURE 46PHARMACEUTICAL PACKAGING EQUIPMENT MARKET (GLOBAL): SME EVALUATION QUADRANT, 2022155
9.6PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: COMPANY FOOTPRINT156
TABLE 129COMPANY FOOTPRINT156
TABLE 130PRIMARY PACKAGING EQUIPMENT: COMPANY FOOTPRINT157
TABLE 131SECONDARY PACKAGING EQUIPMENT: COMPANY FOOTPRINT158
TABLE 132TYPE: COMPANY FOOTPRINT159
TABLE 133REGION: COMPANY FOOTPRINT161
9.7COMPETITIVE BENCHMARKING162
TABLE 134PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES162
TABLE 135PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES163
9.8COMPETITIVE SITUATIONS AND TRENDS165
9.8.1PRODUCT LAUNCHES165
TABLE 136PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PRODUCT LAUNCHES, APRIL 2020–JANUARY 2023165
9.8.2DEALS166
TABLE 137PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DEALS, JANUARY 2021–MARCH 2023166
10COMPANY PROFILES169
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
10.1KEY PLAYERS169
10.1.1GEA GROUP AKTIENGESELLSCHAFT169
TABLE 138GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW169
FIGURE 47GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT170
TABLE 139GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED170
TABLE 140GEA GROUP AKTIENGESELLSCHAFT: PRODUCT LAUNCHES & DEVELOPMENTS171
TABLE 141GEA GROUP AKTIENGESELLSCHAFT: DEALS172
10.1.2I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A173
TABLE 142I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A : COMPANY OVERVIEW173
TABLE 143I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A: PRODUCT/SOLUTIONS/SERVICES OFFERED173
10.1.3SYNTEGON TECHNOLOGY GMBH176
TABLE 144SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW176
TABLE 145SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED177
TABLE 146SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES178
TABLE 147SYNTEGON TECHNOLOGY GMBH: DEALS178
10.1.4ACG180
TABLE 148ACG: COMPANY OVERVIEW180
TABLE 149ACG: PRODUCTS/SOLUTIONS/SERVICES OFFERED180
10.1.5THERMO FISHER SCIENTIFIC INC.183
TABLE 150THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW183
FIGURE 48THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT184
TABLE 151THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED184
TABLE 152THERMO FISHER SCIENTIFIC INC.: DEALS185
10.1.6ROMACO GROUP187
TABLE 153ROMACO GROUP: COMPANY OVERVIEW187
TABLE 154ROMACO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED187
TABLE 155ROMACO GROUP: PRODUCT LAUNCHES188
TABLE 156ROMACO GROUP: DEALS189
10.1.7KÖRBER AG190
TABLE 157KÖRBER AG: COMPANY OVERVIEW190
FIGURE 49KÖRBER AG: COMPANY SNAPSHOT191
TABLE 158KÖRBER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED191
TABLE 159KÖRBER AG: DEALS192
10.1.8MARCHESINI GROUP193
TABLE 160MARCHESINI GROUP: COMPANY OVERVIEW193
TABLE 161MARCHESINI GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED193
TABLE 162MARCHESINI GROUP: PRODUCT LAUNCHES194
TABLE 163MARCHESINI GROUP: DEALS195
10.1.9MG2 S.R.L196
TABLE 164MG2 S.R.L.: COMPANY OVERVIEW196
TABLE 165MG2 S.R.L.: PRODUCTS/SOLUTIONS/SERVICES OFFERED196
TABLE 166MG2 S.R.L.: PRODUCT LAUNCHES197
10.1.10GLATT GMBH198
TABLE 167GLATT GMBH: COMPANY OVERVIEW198
TABLE 168GLATT GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED199
10.2OTHER PLAYERS200
10.2.1BAKER PERKINS200
TABLE 169BAKER PERKINS: COMPANY OVERVIEW200
10.2.2BAUSCH+STRÖBEL201
TABLE 170BAUSCH+ STRÖBEL: COMPANY OVERVIEW201
10.2.3COPERION202
TABLE 171COPERION: COMPANY OVERVIEW202
10.2.4ELIZABETH COMPANIES203
TABLE 172ELIZABETH COMPANIES: COMPANY OVERVIEW203
10.2.5FETTE COMPACTING203
TABLE 173FETTE COMPACTING: COMPANY OVERVIEW203
10.2.6FREUND-VECTOR204
TABLE 174FREUND-VECTOR: COMPANY OVERVIEW204
10.2.7KORSCH205
TABLE 175KORSCH: COMPANY OVERVIEW205
10.2.8L.B. BOHLE206
TABLE 176L.B. BOHLE: COMPANY OVERVIEW206
10.2.9LFA MACHINES206
TABLE 177LFA MACHINES: COMPANY OVERVIEW206
10.2.10CVC TECHNOLOGIES, INC.207
TABLE 178CVC TECHNOLOGIES, INC.: COMPANY OVERVIEW207
10.2.11OHARA TECHNOLOGIES207
TABLE 179OHARA TECHNOLOGIES: COMPANY OVERVIEW207
10.2.12PRISM PHARMA MACHINERY208
TABLE 180PRISM PHARMA MACHINERY: COMPANY OVERVIEW208
10.2.13SAINTYCO209
TABLE 181SAINTYCO: COMPANY OVERVIEW209
10.2.14SILVERSON209
TABLE 182SILVERSON: COMPANY OVERVIEW209
10.2.15YENCHEN MACHINERY210
TABLE 183YENCHEN MACHINERY: COMPANY OVERVIEW210
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
11ADJACENT AND RELATED MARKETS211
11.1INTRODUCTION211
11.2LIMITATIONS211
11.3SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT212
11.3.1INTRODUCTION212
TABLE 184SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT, 2019–2022 (USD MILLION)212
TABLE 185SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT, 2023–2028 (USD MILLION)212
11.4IDM FIRMS213
11.4.1FOCUS ON SEMICONDUCTOR DESIGN AND PRODUCTION AND HAVE INTERNAL CAPABILITY TO PERFORM BOTH213
TABLE 186IDM FIRMS: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)213
TABLE 187IDM FIRMS: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)214
11.5OSAT COMPANIES214
11.5.1LESS INVESTMENTS AND ATTRACTIVE REVENUE FOSTER GROWTH OF OSAT COMPANIES214
TABLE 188OSAT COMPANIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)215
TABLE 189OSAT COMPANIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)215
11.6FOUNDRIES215
11.6.1INCREASED SEMICONDUCTOR OUTSOURCING BY FABLESS COMPANIES215
TABLE 190FOUNDRIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION)216
TABLE 191FOUNDRIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION)216
12APPENDIX217
12.1INSIGHTS FROM INDUSTRY EXPERTS217
12.2DISCUSSION GUIDE218
12.3KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRI
Related Report
